US-Mexico Trade Agreement Elicits Another Battle Over Biologics Data Exclusivity
Agreement in principle between US and Mexico would establish 10 years of data protection for biologic drugs, which AAM opposes.
Agreement in principle between US and Mexico would establish 10 years of data protection for biologic drugs, which AAM opposes.